HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CVS Reformulating Own-Brand Sunscreens Without Alleged Coral Killers

Executive Summary

“CVS Pharmacy is highly attuned to our customers’ evolving needs and their desire for products that are more sustainable while still being efficacious,” says CVS Health’s George Coleman, senior vice president of merchandising. The retailer is committed to eliminating oxybenzone and octinoxate from CVS-branded sunscreens with SPFs less than 50 by the end of 2020.

You may also be interested in...



Cosmetics Market In 2019: CBD, Microplastic And US Sunscreen Uncertainty Among Year’s Biggest Issues

The opportunity represented by cannabidiol, and the uncertain future for commonly used sunscreen active ingredients in the US and microplastic in the EU, were issues of high interest among cosmetics industry stakeholders in 2019.

Mineral Sunscreens Threaten Marine Ecosystems? L’Oreal Hair Care Built On Stolen IP? Personal Care News In Brief

A new study published by university researchers in Spain raises questions about the impact of mineral sunscreens – specifically their release of trace metals and inorganic nutrients – on marine environments. More personal-care news.

Top Retailers Driving Chemical Policy Adherence With ‘Clean Beauty’ Seals

What exactly is “clean beauty”? At Target and Sephora, it means phasing out many traditional preservatives, among other commonly used but “unwanted” ingredients, and getting prominent placement and the retailers’ “Clean” stamps of approval in return.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS149214

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel